Treatment of Rhinitis Medicamentosa in Pregnancy

Rhinitis medicamentosa presenting in a pregnant patient requires a management approach that accounts for the unique physiological and safety considerations of pregnancy.

Clinical scenario

This protocol addresses the pregnant patient with rhinitis medicamentosa — a condition arising from prolonged topical nasal decongestant use. Pregnancy introduces specific constraints on therapeutic choices, particularly regarding certain classes of oral agents in the first trimester.

Treatment approach

Management centres on discontinuing intranasal decongestant use, with nasal corticosteroid therapy as a key component — alongside pregnancy-specific considerations that restrict certain oral medication classes.

Full sequencing, additional interventions, and pregnancy-specific guidance are available in the complete protocol below.

Instant Access to Structured Evidence-Based Regimens

References

Therapy for a pregnant patient with RM generally is the same as outlined above, although oral decongestants should be avoided in the first trimester because of risk of gastroschisis.

View source ↗